Allergan to buy US drug developer Vitae Pharmaceuticals for $639 million

Shares of Allergan jumped after announcing it would buy drug developer Vitae Pharmaceuticals for about $639 million.

from Mergers and Acquisitions http://ift.tt/2d03K3k